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Many pathogenic organisms produce pore-
forming toxins as virulence factors. Target cells
however mount a response to such membrane
damage. Here we show that toxin-induced
membranepermeabilization leads to adecrease
in cytoplasmic potassium, which promotes the
formation of a multiprotein oligomeric innate
immune complex, called the inflammasome,
and the activation of caspase-1. Further, we
find that when rendered proteolytic in this con-
text caspase-1 induces the activation of the
central regulators of membrane biogenesis,
the Sterol Regulatory Element Binding Proteins
(SREBPs), which in turn promote cell survival
upon toxin challenge possibly by facilitating
membrane repair. This study highlights that, in
addition to its well-established role in triggering
inflammation via the processing of the precur-
sor forms of interleukins, caspase-1 has a
broader role, in particular linking the intracellu-
lar ion composition to lipidmetabolic pathways,
membrane biogenesis, and survival.
INTRODUCTION
Pathogenic micro-organisms, and in particular bacteria,
often produce pore-forming proteins as virulence factors
(van der Goot, 2001). These proteins are either bonafide
pore-forming toxins or components of type III secretion
apparatus involved in perforating the host plasma mem-
branes to allow the injection of bacterial effectors neces-
sary for infection (Mota et al., 2005). The size of the pores
varies from 1–2 nm for pore-forming toxins such as aero-
lysin fromAeromonas hydrophila (Abrami et al., 2000) or a-
toxin from Staphylococcus aureus (Bhakdi and Tranum-
Jensen, 1991), to 25–30 nm for Cholesterol DependentCell 12Toxin such as pneumolysin or listeriolysin O (Shatursky
et al., 1999). Depending on the toxin, its concentration,
and the type of target cell, the outcome of the toxin-
induced plasma membrane perforation may also vary.
The two extreme cases are osmotic lysis of erythrocytes,
which are not necessarily physiological targets of these
toxins, and full-membrane repair and cell survival (Walev
et al., 2001; Walev et al., 1994). The most common out-
come in vitro is however cell death—which can be apopto-
tic or necrotic but has generally not been characterized
(Abrami et al., 2000). Little is known however about the
underlying cellular mechanisms.
Here we were interested in cellular responses to pore-
forming toxins, in particular survival mechanisms. We
used aerolysin as a prototype since it is well characterized
(Abrami et al., 2000), and a variety of inactive mutants are
available (Fivaz et al., 2002; Tsitrin et al., 2002). The toxin is
secreted by Aeromonas species as an inactive precursor,
called proaerolysin, which must be proteolytically pro-
cessed by gut enzymes or by proteases of the furin family
(Abrami et al., 2000). The precursor, as well as the mature
toxin, binds specifically to GPI-anchored proteins at the
surface of target cells (Abrami et al., 2000). Once bound
and processed, the toxin heptamerizes into a circular
ring, a process that is promoted by lipid rafts (Abrami
and van der Goot, 1999). Toxin oligomerization leads to
the exposure of hydrophobic surfaces that drive mem-
brane insertion (Iacovache et al., 2006). Pore formation
renders the plasma membrane permeable to small ions
but not proteins (Abrami et al., 2000). Specific cellular ef-
fects observed upon aerolysin treatment are release of
calcium from the endoplasmic reticulum (ER); vacuolation
of the ER (Abrami et al., 2000); and production of proin-
flammatory molecules such as tumor necrosis factor
a (TNFa), interleukin 1b, interleukin 6, and prostaglandin
E2 (Chopra et al., 2000; Galindo et al., 2004a). We show
here that, by allowing the efflux of intracellular potassium,
aerolysin triggers the activation of caspase-1. This cyste-
ine protease is produced as a 45 kDa precursor that
requires autocatalytic processing for activation.6, 1135–1145, September 22, 2006 ª2006 Elsevier Inc. 1135
Autoproteolysis depends on the formation of a large mul-
tiprotein oligomeric complex called the inflammasome
(Martinon and Tschopp, 2005), which brings procas-
pase-1 molecules in close proximity of one another. Two
types of inflammasomes have been reported, each con-
taining a different member of the intracellular pattern rec-
ognition receptors, the so-called NLR (NACHT-LRR) fam-
ily of proteins (Martinon and Tschopp, 2005). NLR
members are typically composed of three domains: a leu-
cine rich repeat (LRR) ligand-sensing domain, a NACHT
oligomerization domain, and a C-terminal homotypic pro-
tein-protein interaction domain that can be either a cas-
pase recruitment domain (CARD) or a pyrin domain. Re-
cently some natural stimuli of the inflammasomes have
been identified, such as uric acid crystals associated
with Gout (Martinon et al., 2006), bacterial RNA (Kanne-
ganti et al., 2006), extracellular ATP, the calcium channel
affecting marine toxin maitotoxin (Mariathasan et al.,
2006) and cytoplasmic flagellin (Franchi et al., 2006;
Miao et al., 2006), leading to the view that inflammasomes
are intracellular detectors of danger signals. Two NLR
members can induce caspase-1 activation: NALP and
IPAF. Genomic analysis has revealed 14 NALPs in the hu-
man genome, of which NALP1 and NALP3 have been best
characterized and shown to be involved in caspase-1
activation (Chamaillard et al., 2003). The interaction of
NALPs with caspase-1 is not direct and depends on the
adaptor protein ASC (apoptosis-associated speck-like
protein containing a CARD) (Martinon and Tschopp,
2005). IPAF, for which only one form has been reported,
in contrast associates directly with caspase-1 via its C-
terminal CARD domain (Martinon and Tschopp, 2005), al-
though direct or indirect interactions with ASC may exist
(Mariathasan et al., 2004; Sutterwala et al., 2006).
We here found that aerolysin-induced K+ efflux triggers
the assembly of IPAF and the NALP3 inflammasomes and
the activation of caspase-1. Most importantly, we found
that caspase-1 then induces the activation of the central
regulators of membrane biogenesis, the sterol regulatory
element binding proteins (SREBPs), which in turn promote
cell survival upon toxin challenge. This study highlights
that, in addition to its well-established role in triggering in-
flammation via the processing of the precursor forms of in-
terleukins 1b, 18 (Fantuzzi and Dinarello, 1999), and 33
(Schmitz et al., 2005), caspase-1 has a broader role than
previously appreciated, in particular linking the intracellu-
lar ion composition to lipid metabolic pathways.
RESULTS AND DISCUSSION
Pore Formation by Aerolysin Leads to the Activation
of SREBPs
To study the cellular response to pore-forming toxins, we
performed an RNA differential display analysis using the
highly sensitive amplification of double-stranded cDNA
end restriction (ADDER) fragments method (Kornmann
et al., 2001). Chinese hamster ovary (CHO) cells were
treated with low concentrations of proaerolysin (0.1 nM1136 Cell 126, 1135–1145, September 22, 2006 ª2006 Elsevie[Ratner et al., 2006]), conditions under which all cells ex-
cluded the DNA-intercalating agent propidium iodide for
at least 10 hr (Figure S1A) (note that the protoxin is pro-
cessed to aerolysin by cell-surface proteases, leading to
pore formation). The ADDER analysis led to the identifica-
tion of various differentially expressed genes, in particular
the sterol regulatory element binding protein-2 (SREBP-2),
which was upregulated after 3 hr (Figure S1B). SREBPs
are membrane bound transcription factors that regulate
the expression of genes harboring a sterol responsive el-
ement (SRE) in their promoter region and which are typi-
cally involved in cholesterol and fatty acid biosynthesis
(for review see Goldstein et al., 2006). SREBPs initially re-
side in the ER. Release of the transcription factor domain
from themembrane requires sequential proteolysis by two
transmembrane enzymes, S1P and S2P, which reside in
the Golgi apparatus. Cleavage of SREBPs thus requires
transport from the ER to the Golgi, a step that is controlled
by the escort protein SCAP (Goldstein et al., 2006). The
following three major SREBP isoforms are known:
SREBP-1a and -1c, which are encoded by a single gene
and are preferentially involved in fatty acid metabolism,
and SREBP-2, which is encoded by a distinct gene and
controls cholesterol and lipid biosynthesis (Goldstein
et al., 2006; Horton and Shimomura, 1999). Different stim-
uli have been reported to induced SREBP activation, in-
cluding cholesterol depletion (Goldstein et al., 2006), ER
calcium depletion (Lee and Ye, 2004), growth factors
and insulin signaling (Demoulin et al., 2004; Nadeau
et al., 2004), phagocytosis (Castoreno et al., 2005), and
exposure of cells to hypotonic media (Lee and Ye, 2004).
Since regulation of SREBPsmainly occurs at the protein
level rather than the transcriptional level, we tested
whether aerolysin triggers SREBP-2 processing. Mem-
brane and nuclear fractions were prepared from toxin-
treated cells and probed by Western blotting using an an-
tibody against the N terminus of SREBP-2. In untreated
cells, full-length SREBP-2 (123 kDa) was found in the
membrane fraction (Figure 1A), as expected since cells
were grown in the presence of serum, the high-lipid con-
tent of which suppresses SREBP activation. Upon aeroly-
sin treatment, the amount of full-length SREBP-2 de-
creased with time with the concomitant appearance of
an 60 kDa form in the nuclear fraction. Migration of
SREBP-2 to the nucleus was confirmed by immunofluo-
rescence microscopy (Figure 1B). Interestingly, the sec-
ond SREBP isoform, SREBP-1, also underwent activation
upon toxin treatment (Figure 1C). These results show that
aerolysin caused the proteolytic processing and nuclear
translocation of SREBPs.
We next measured the effect of aerolysin on the mRNA
levels of two SREBP target genes: HMGCoA reductase
and fatty acid synthase activated by SREBP-2 and
SREBP-1 respectively (Horton and Shimomura, 1999).
Both mRNAs increased upon toxin addition as shown by
real-time PCR (Figures 1D and 1E, >3 fold after 3 hr).
Also, the total cellular cholesterol increased by 25% to
30% after 3–5 hr toxin treatment (Figure 1F). Similarr Inc.
Figure 1. Aerolysin Triggers the Activa-
tion of SREBPs
(A) CHO cells were treated or not for 1, 2, or 3 hr
with 0.2 nM proaerolysin. Membrane and nu-
clear fractions were prepared and probed for
the presence of SREBP-2.
(B) Immunofluorescence against SREBP-2 of
CHO cells treated or not with 0.2 nM aerolysin
for 3 hr. Bar is 10 mm.
(C)–(E) CHO cells were treated as in (A), and
cellular fractions were probed for SREBP-1. In
(D) and (E), RNA was extracted from CHO cells
treated or not with 0.2 nM proaerolysin for 1, 3,
or 5 hr. Levels of HMGCoA reductase (D) and
fatty acid synthase (E) mRNAs were quantified
and normalized to the levels ofmRNAs of trans-
lation elongation factor 1 a1 and transcription
factor TATA Binding Protein, which did not sig-
nificantly change upon toxin treatment. Error
bars represent standard deviations (n = 3).
(F) CHO cells were treated as in (A), and the
cellular cholesterol levels were determined
and normalized to protein concentration. Error
bars represent standard deviations (n = 3).increases were observed whether cells were incubated in
serum-freemedium or in serum-containing medium, in the
presence or absence of the cholesterol synthesis inhibitor
lovastatin (not shown), indicating that cholesterol could
be synthesized as well as taken up from the medium, in
agreement with the regulatory effect of SREBP-2 on tran-
scription of the LDL receptor gene.
Altogether, these observations show that aerolysin trig-
gers the activation of SREBPs, the subsequent upregula-
tion of genes under the control of SREs, and the increase
of cellular cholesterol.
Toxin-Induced K+ Efflux Triggers
SREBP-2 Activation
To understand the mechanisms that mediate aerolysin-in-
duced SREBP activation, we first investigated whether
pore formation was required by using two inactive aeroly-
sin mutants: ASSP, which binds to GPI-anchored proteins
but is unable to form heptamers (Fivaz et al., 2002), and
Y221G, which binds to GPI-anchored proteins and forms
heptamers but is unable to insert into membranes (Tsitrin
et al., 2002). Neither mutant affected SREBP-2, indicating
that pore formation is necessary for activation of the tran-
scription factor (Figure 2A). Since the same purification
procedure was used for wild-type (WT) and mutant toxins,
these observations also indicate that aerolysin-induced
SREBP activation is not due to contaminating bacterial
products, and in particular, lipopolysaccharide (LPS).
This was confirmed by the lack of effect of LPS binding an-
tibiotic polymixin B on aerolysin-induced SREBP-2 activa-
tion (Figure S2A). Pore formation per se thus appeared to
be required for SREBP-2 activation. We thus wondered
whether another pore-forming toxin would trigger the
same lipogenic response, and a-toxin form Staphylococ-
cus aureus was chosen since its mode of action and pore
size are very similar to that of aerolysin (Bhakdi and Tra-Cell 1num-Jensen, 1991). In HeLa cells (CHO cells are insensi-
tive to a-toxin), both aerolysin (see Figure 3A) and Staphy-
lococcal a-toxin induced SREBP-2 activation (Figure 2B).
Since SREBP-2 is an ER membrane protein and we
have previously shown that aerolysin triggers fragmenta-
tion and vacuolation of the ER (Abrami et al., 1998), we in-
vestigated whether SREBP-2 activation was due to toxin-
induced ER alterations. Vacuolation can be prevented
either by the addition of sucrose to the medium (unpub-
lished data) or by chelating extracellular calcium (Abrami
et al., 1998). Neither extracellular sucrose (Figure S2B)
nor EGTA (Figure S2C) prevented SREBP-2 activation.
These experiments also indicate that SREBP-2 activation
is not due to calcium entry. A role of elevated intracellular
calciumwas further ruled out by the use of the intracellular
calcium chelator BAPTA-AM, which had no effect on
SREBP-2 activation (data not shown).
We then tested whether exit of potassium, through the
toxin pores, could be the trigger for SREBP-2 activation.
Cells were treated with aerolysin in a high (150 mM KCl)
or low (5 mM KCl) K+-containing medium or in tissue-cul-
ture medium (containing serum). No K+ efflux was ob-
served upon toxin treatment in high K+ medium (data not
shown), as expected, but, remarkably, SREBP-2 was not
activated (Figure 2C), suggesting that K+ effluxwas neces-
sary. To test whether K+ efflux was sufficient, cells were
treated with the K+ ionophore valinomycin, and SREBP-2
activation was readily observed (Figure 2D). In contrast,
monensin, a sodium ionophore (which was active under
our experimental conditions, Figure S3), had no effect
(data not shown), suggesting that SREBP-2 activation is
due to K+ efflux and not membrane depolarization.
It has previously been reported that thapsigargin-
induced ER calcium release leads to SREBP activation
(Lee and Ye, 2004). Although aerolysin also leads to ER
calcium release (Krause et al., 1998), this event is not26, 1135–1145, September 22, 2006 ª2006 Elsevier Inc. 1137
Figure 2. Aerolysin-Induced K+ Efflux
Triggers both SREBP-2 Maturation
and Inflammasome-Mediated Caspase-1
Activation
(A) CHO cells were treated or not with 0.2 nM
WT or ASSP and Y221G proaerolysins for
3 hr. Membrane and nuclear fractions were
probed for the presence of SREBP-2.
(B) HeLa cells were treated for different times
with Staphylococcal a-toxin (30 nM). Mem-
brane and nuclear fractions were probed for
SREBP-2.
(C) CHO cells, in tissue-culture medium (Cul-
ture), Hanks buffer (low K+), or a modified
Hanks buffer in which the sodium and K+ con-
centrations were inverted (High K+), were
treated or not with 0.2 nM proaerolysin for
3 hr. Cellular fractions were analyzed as in (A).
(D) CHO cells were treated for different times
with 10 mM of valinomycin. Cellular fractions
were analyzed as in (A).
(E and F) CHO cells were treated or not with 0.2
nMWT or Y221G proaerolysin or 10 mM of vali-
nomycin for 3 hr in either tissue-culturemedium
(Culture, Cult.), Hanksbuffer (lowK+), orHighK+
as in (C). Activation of caspase-1 was moni-
tored (E) byWestern blotting to detect process-
ing of the 45 kDa procaspase-1 or (F) using the
fluorescent reagent, FLICACasp1. Error bars rep-
resent standard deviations (n = 3).
(G) HeLa cells were transiently transfected (24
hr) with RNAi duplexes against ASC, NALP3,
and IPAF in single to triple transfections. Two
duplex sequences, labeled 1 and 2, were used
for NALP3 and IPAF. Cells were then treated
with proaerolysin for 3 hr at 0.2 nM, and
caspase-1 activation was monitored using
FLICACasp1. Under each RNAi condition, the
number of FLICACasp1-positive cells in the ab-
sence of toxin was extremely low and thus not
visible ona yaxis ranging from0%to80%.Error
bars represent standard deviations (n = 3).necessary for K+ efflux-mediated SREBP-2 activation
since valinomycin, which efficiently triggers SREBP-2 ac-
tivation, has no effect on ER calcium (data not shown).
Aerolysin Triggers Inflammasome-Mediated
Activation of Caspase-1
The above experiments show that the event that is sensed
upstream of SREBP activation is the loss of intracellular
K+. Potassium efflux, triggered by Staphylococcal a-toxin
(Walev et al., 2000), K+ ionophores (Mariathasan et al.,
2006; Perregaux and Gabel, 1994), or activation of the
P2X7 receptor by extracellular ATP (Kahlenberg and Du-
byak, 2004; Mariathasan et al., 2006), has been shown
to activate caspase-1. We therefore analyzed the effect
of aerolysin on caspase-1. As shown in Figure 2E, WT,
but not Y221G mutant, aerolysin led to the processing of
procaspase-1. Caspase-1 cleavage was however only
observed when extracellular K+ was low (Figure 2E), indi-
cating that K+ efflux was necessary and indeed caspase-1
activation could also be triggered by valinomycin1138 Cell 126, 1135–1145, September 22, 2006 ª2006 Elsevier(Figure 2E). Identical observations were made when
using the commercially available fluorescent reagent,
FLICACasp1, that binds to the active form of caspase-1
with high affinity (Figure 2F). Importantly, caspase-1 acti-
vation was equally observed with polymixin B-treated
WT aerolysin, ruling out a role of contaminating LPS (Fig-
ure S4A). Finally aerolysin specifically activated caspase-
1, since caspase-3 was not activated as monitored by
Western blotting (data not shown) or using the caspase-
3 specific FLICACasp3 reagent (Figure S4B).
To investigate whether the inflammasomes are involved
in sensing the aerolysin-induced K+ efflux, we silenced ex-
pression of IPAF, NALP3, and/or ASC by siRNA. All duplex
RNAis efficiently reduced the levels of the corresponding
mRNAs (Figure S5A) aswell as the expression of the corre-
sponding FLAG-tagged proteins (Figure S5B). Interest-
ingly, knock down of ASC, NALP3, or IPAF individually
led to a 30%–50%decrease in the number of cells inwhich
caspase-1 was activated in response to aerolysin
(Figure 2G), whereas the transfection of four irrelevantInc.
Figure 3. Aerolysin-Induced SREBPActi-
vation Is Caspase-1 Dependent but S1P
and S2P Mediated
(A) As shown in the left panel, CHO cells were
treated or not with the caspase-1 inhibitor
YVAD (100 mM) for 1 hr, followed by 3 hr with
proaerolysin (0.2 nM), still in the presence or
absence of inhibitor. Membrane and nuclear
fractions were probed for the presence of
SREBP-2. As shown in the right panel, HeLa
cells were transiently transfected (24 hr) with
RNAi duplexes against ASC, NALP3 (sequence
1), and IPAF (sequence 1), followed by 3 hr
treatment with 0.2 nM proaerolysin. Membrane
and nuclear fractions were prepared and ana-
lyzed (80 mg) for the presence of SREBP-2.
(B) HeLa cells were transiently transfected (24
hr) with RNAi duplexes against caspase-1 or
-3, followed by 3 hr treatment with 0.2 nM
proaerolysin. Membrane and nuclear fractions
were probed for the presence of SREBP-2
(left panel) or SREBP-1 (right panel).
(C) CHO cells were treated either with b-
methyl-cyclodextrin (ßMCD, 10 mM) in a se-
rum-freemedium for 1 hr or with 0.2 nMproaer-
olysin for 3 hr. Nuclear fractions were probed
for SREBP-2.
(D) HeLa cells were transiently transfected (48
hr) with RNAi duplexes against SCAP, S1P, or
S2P, followed by 3 hr treatment with 0.2 nM
proaerolysin. Membrane and nuclear fractions
were probed for the presence of SREBP-2.
(E) S1P- or S2P-deficient CHO cells and the
corresponding recomplemented CHO were
treated with 0.2 nM proaerolysin for 3 hr. Mem-
brane and nuclear fractions were probed for
the presence of SREBP-2. Two different expo-
sures of the membrane fraction are shown.siRNAs had no effect (Figure S6A). Double transfection
with siRNAagainst ASCandNALP3didnot lead toa further
decrease,whereas knockingdownASCand IPAF together
essentially abolished caspase-1 activation, as did triple
transfection against all three components (Figure 2G).
Again triple transfection using irrelevant siRNAs had no ef-
fect (Figure S6A). The inhibitory effect of these siRNAs
were specific for inflammasome-mediated pathways since
cotransfection of siRNAs against ASC and IPAF for exam-
pledid not prevent activationof the interferonbpathwayby
Sendai virus (Strahle et al., 2006) (Figure 7).
These results show that aerolysin induces activation of
caspase-1 through the assembly of both the IPAF and
the NALP3 inflammasomes. It is interesting to note that
toxin-induced K+ efflux is to our knowledge the first stim-
ulus that simultaneously activates both inflammasomes,
raising the possibility that for such a severe stress, nature
has conceived a backup pathway.
Aerolysin-Induced SREBP Activation Is
Caspase-1 Mediated
Aerolysin-induced K+ efflux triggers activation of both cas-
pase-1 and SREBP-2. To determine whether these events
lie inacommonpathway,we investigatedwhetherprevent-Cell 12ing one would affect the other. Remarkably, the caspase-1
inhibitor YVAD completely blocked aerolysin-induced
SREBP-2 activation (Figure 3A, left panel), whereas the
caspase-3 inhibitor DEVD had no effect (data not shown).
Aerolysin-induced SREBP-2 activation could also be pre-
vented by knocking down the inflammasomes using
siRNAs against NALP3, ASC, and IPAF (Figure 3A, right
panel) or by directly knocking down the expression of cas-
pase-1 (Figure 3B, left panel). This effect was specific to
caspase-1 since RNAi against caspase-3 had no effect
(Figure 3B, left panel). RNAi against caspase-1, but not
caspase-3, also prevented aerolysin-induced activation
of SREBP-1 (Figure 3B, right panel). These observations
show that caspase-1 activation lies upstream and is
required for SREBP activation. In agreement with this
sequence of events, preventing activation of SREBP-2
(see Experimental Procedures below) had no effect on
aerolysin-induced caspase-1 activation (Figure S9B).
Caspase-1 Triggers S1P- and S2P-Mediated
SREBP Activation
Since caspase-1 is a protease and since activation of
SREBPs involves proteolysis, we investigated the possi-
bility of a direct activation. Hamster SREBP-1 and -26, 1135–1145, September 22, 2006 ª2006 Elsevier Inc. 1139
Figure 4. Preventing Caspase-1-Medi-
ated SREBP-2 Maturation Promotes
Aerolysin-Induced Cell Death
(A) CHO cells were incubated in tissue-culture
medium (Culture) or Hanks buffer (low K+) or
a modified Hanks buffer, in which the sodium
and potassium concentrations were inverted
(High K+). Cells were treated for 1 min with dif-
ferent concentrations of proaerolysin and then
incubated in the corresponding medium for
4 hr prior to propidium iodide staining. Error
bars represent standard deviations (n = 3).
(B) HeLa cells were transiently transfected (24
hr) with RNAi duplexes against ASC, NALP3,
and IPAF in single to triple transfections. Two
duplex sequences, labeled 1 and 2, were
used for NALP3 and IPAF. Cells were then
treated as in (A).
(C) CHO cells were treated or not with either the
caspase-1 inhibitor YVAD (100 mM) or the cas-
pase-3 inhibitor DEVD (100 mM) for 1 hr, fol-
lowed by 3 hr with proaerolysin (0.2 nM), then
stainedwith propidium iodide. Error bars repre-
sent standard deviations (n = 3).each contain a potential caspase-1 cleavage site in their
N-terminal cytoplasmic region that would lead to a 3
kDa and 27 kDa form respectively. These forms would
however not contain the helix-loop-helix DNA binding do-
main and thus be inactive. SREBPs in addition contain nu-
merous aspartic acid residues at the amino side of the first
transmembrane region, which could be unconventional
caspase-cleavage sites. We first compared the migration
patterns of the nuclear forms of SREBP-2 obtained
through aerolysin activation of caspase-1 or by sterol dep-
rivation. The migration pattern of SREBP-2 was indistin-
guishable for cells treated with aerolysin or the choles-
terol-extracting drug b-methyl cyclodextrin (Figure 3C,
4%–12% acrylamide gradient gels were used tomaximize
the resolution in the 50 kDa size range), suggesting that
cleavage occurred at the same sites and thus possibly
by the same enzymes.
To test whether aerolysin-induced activation of SREBP-
2 occurs via the well-established SCAP-, S1P-, and S2P-
dependent pathway (Goldstein et al., 2006), we performed
RNAi against these three proteins (Figure S8). Knocking
down the escort protein SCAP or one of the two proteases
prevented the aerolysin-induced activation of SREBP-2
(Figure 3D). To further strengthen the involvement of S1P
and S2P, we made use of mutant CHO cell lines deficient
in either of the proteases (Rawson et al., 1997, 1998). The
mature form of SREBP-2 could not be detected in nuclear
extracts of aerolysin-treated S1P/ or S2P/ cells, in
contrast to the recomplemented cells (Figure 3E).
SREBP-2 remained full-length in S1P/ cells, whereas
an intermediate, membrane bound form could be de-
tected in S2P/ cells consistent with a first cleavage
event by S1P. Recomplementation of cells with the appro-1140 Cell 126, 1135–1145, September 22, 2006 ª2006 Elsevierpriate protease led to the recovery of toxin-induced
SREBP-2 activation. Altogether these observations show
that SREBP-2 activation induced by aerolysin depends
on SCAP and the sequential processing by S1P and S2P.
Toxin-Induced Activation of the SREBP Pathway
Promotes Cell Survival
Having outlined a new signaling pathway linking toxin-in-
duced membrane permeabilization to the activation of
lipogenic genes, we investigated whether this pathway
plays a role in cell survival. For this, we interfered with dif-
ferent steps along the pathway and monitored cell death
by propidium iodide staining. Aerolysin-induced K+ efflux
was prevented by incubating cells in high-K+ medium.
Caspase-1 activationwas prevented either by using a cas-
pase-1 inhibitor or RNAi against various components of
the inflammasomes, including caspase-1 itself. SREPB2
activation was inhibited using 25-hydroxycholesterol
(25OHChol), a well-established inhibitor of SREBP activa-
tion (Wang et al., 1994), by overexpression of INSIG-1
(Castoreno et al., 2005; Yang et al., 2002), a multispanning
membrane protein involved in the retention of SREBP-2 in
the ER (Goldstein et al., 2006), by RNAi against SCAP,
S1P, S2P, or directly against SREBP-1 or -2. And finally,
the effect of inhibiting enzymes upregulated by SREBPs
was probed by using cerulenin, an inhibitor of fatty acid
synthase (Walev et al., 1994).
Death was increased when cells were treated with aero-
lysin in a high-K+ medium (Figure 4A). Cell death was also
promoted upon simultaneous RNAi knock down of the
NALP3 and IPAF inflammasomes (Figure 4B), whereas
RNAi against irrelevant proteins had no effect (Figure S6B).
Knocking down one of the two inflammasomes, however,Inc.
Figure 5. Interfering with the SREBP
Pathway Promotes Aerolysin-Induced
Cell Death
(A and B) CHO cells were treated or not with
1mg /ml 25 hydroxycholesterol (25OH Chol) or
19 hydroxycholesterol (19OH Chol) for 1 hr at
37C. In (A), cells were additionally treated or
not with 0.2 nMproaerolysin for 3 hr in the pres-
ence or not of the drugs. Membrane and nu-
clear fractions were probed for the presence
of SREBP-2. In (B), cells were treated for
1 min with different concentrations of proaero-
lysin and then incubated in tissue-culture me-
dium, in the presence of the drugs, for 4 hr prior
to propidium iodide staining. Error bars repre-
sent standard deviations (n = 3).
(C) HeLa cells overexpressing or not human
INSIG-1were treated or notwith bmethylcyclo-
dextrin (ßMCD, 10 mM) (left panel) or 0.2 nM
proaerolysin for 3 hr (right panel). Membrane
and nuclear fractions were probed for the pres-
ence of SREBP-2. Total cells extracts were
probed for myc-tagged INSIG-1.
(D) HeLa cells overexpressing INSIG-1 were
treated for 1 min with different concentrations
of proaerolysin and then incubated in tissue-
culture medium for 4 hr and analyzed as in (B).
(E) HeLa cells were transiently transfected (48
hr) with RNAi duplexes against SREBP-1,
SREBP-2, and SCAP. Cells were treated and
analyzed as in (B).
(F) S1P- or S2P-deficient CHO cells and the
corresponding recomplemented CHO were
treated and analyzed as in (B). The inset shows
S1P- or S2-deficient CHO cells and corre-
sponding recomplemented cells treated for
3 hr with 0.2 nM proaerolysin. Caspase-1 acti-
vation was monitored using FLICACasp1. Error
bars represent standard deviations (n = 3).had no effect on cell death, conditions under which aero-
lysin-induced caspase-1 activation was only moderately
reduced (Figure 2G). In agreement with the death-promot-
ing activity of the inhibitory RNAis, inhibition of caspase-1
using YVAD also led to an increase in cell death, whereas
inhibition of caspase-3 had no effect (Figure 4C).
We next inhibited aerolysin-induced activation of
SREBP-2 using 25OH Chol (Figure 5A). This drug had no
effect on the upstream events such as pore formation
(Figure S9A) or caspase-1 activation (Figure S9B). Cell
death was however strongly increased (Figure 5B). This
effect was specific to aerolysin-induced cell death since
25OH Chol did not enhance death induced by the proa-
poptotic kinase inhibitor staurosporine (Figure S9C). In-
creased cell death was not due to the accumulation of
toxic insults since 19OH Chol, which does not inhibit
SREBP-2 activation (Figure 5B, (Goldstein et al., 2006),
as well as two unrelated inhibitors of cellular activities, leu-
peptin, which inhibits lysosomal enzymes, and bafilomy-
cin, which inhibits the vacuolar proton ATPase, had no ef-
fect on aerolysin-induced cell death (Figures 5B and S9D).
As an alternative to 25OH Chol, we overexpressed
INSIG-1, which prevented SREBP-2 activation both byCell 1sterol extraction with ßMCD (Figure 5C, left panel; Gold-
stein et al., 2006) and by aerolysin (Figure 5C, right panel).
INSIG-1 overexpression had no effect on aerolysin-
induced activation of caspase-1 (Figure S9B) but pro-
moted toxin-induced cell death (Figure 5D). Overexpres-
sion of two irrelevant proteins, the transmembrane
influenza hemaglutinin or the green fluorescent protein,
in the same expression vector, had no effect (Figure S10).
Finally, we investigated whether inhibiting an enzyme that
is upregulated by SREBPs would influence cell death.
Cerulenin, an inhibitor of fatty acid synthase (Walev
et al., 1994), drastically enhanced aerolysin-induced cell
death (Figure S11).
Together these experiments show that interfering with
SREBP activation and function promotes cell death in
response to aerolysin.
Aeromonas-Triggered Caspase-1-Mediated
SREBP-2 Activation Promotes Cell Survival
To test whether the here identified caspase-1-dependent
SREBP-2 activation pathway operates during infection by
a b-hemolytic bacterium, primary human fibroblasts were
infected with Aeromonas trota, an aerolysin-producing26, 1135–1145, September 22, 2006 ª2006 Elsevier Inc. 1141
species responsible for severe diarrhea in humans (Chak-
raborty et al., 1987). The bacterium triggered massive ac-
tivation of caspase-1, in a strictly aerolysin-dependent
manner as demonstrated using the same Aeromonas
strain in which the aerolysin gene had been selectively in-
activated (Figure 6A). Infection of these primary cells with
the WT Aeromonas trota strain also led to a strong activa-
tion of SREBP-2, whereas the aerolysin-deficient strain
had no effect (Figure 6B). Finally, WT Aeromonas, but
not the aerolysin deficient strain, induced cell death, and
death was increased in 25OH Chol-treated cells (Fig-
ure 6C). Altogether these observations indicate that during
infection, aerolysin leads to the activation of caspase-1
and SREBP-2, and this pathway promoted cell survival.
Figure 6. Aeromonas trota Triggers Caspase-1-Mediated
SREBP-2 Activation in Primary Human Fibroblasts
Primary human fibroblasts were infected with WT (AerA+) or aerolysin-
deficient (AerA) Aeromonas trota at an MOI of 1.5 or treated with 0.2
nM proaerolysin.
(A) Caspase-1 activation was monitored using FLICACasp1. Error bars
represent standard deviations (n = 3).
(B) Cells were harvested after 3 hr. Membrane and nuclear fractions
were probed for the presence of SREBP-2.
(C) Cells were treated or not with 1mg/ml 25 hydroxycholesterol (25OH
Chol) for 1 hr at 37C and then infected as in (A). After 3 hr, cells were
stained with propidium iodide. Error bars represent standard devia-
tions (n = 3).1142 Cell 126, 1135–1145, September 22, 2006 ª2006 ElsevierConcluding Remarks
Here we uncovered a novel signaling pathway that links
changes in cytoplasmic ion composition, due to plasma
membrane permeabilization, to lipid metabolism and cell
survival. Although many details remain to be elucidated,
our data indicate that, in response to a drop in cytosolic
[K+], the followingsequenceofevents is triggered (Figure7).
The drop in intracellular [K+] activates the IPAF and ASC/
NALP3 inflammasomes and allows the processing of cas-
pase-1. Whether the LRR domains of IPAF and NALP3
are the direct sensors of the [K+] decrease remains to be
shown.Once activated, caspase-1 acts on an intermediate
target, which then induces the processing of SREBPs by
S1P and S2P. Mature SREBPs then lead to the upregula-
tion of lipogenic genes (Goldstein et al., 2006), which in
turn promoted cell survival in response to pore formation.
The present work highlights that caspase-1 may have
a far broader role than until now appreciated. In addition
to its well-established roles in the production of proinflam-
matory cytokines (Fantuzzi andDinarello, 1999) and inme-
diating cell death upon infection by certain pathogens (for
review see Cookson and Brennan, 2001), caspase-1 may
be equally important in promoting survival upon pathogen
attack as well as having a more general role as a positive
regulator of lipid metabolism. To fulfill these additional
roles, caspase-1 must modify target proteins other than
the precursor forms of interleukins 1b, 18, and 33. The
identification of these targets will clearly be of an impor-
tant future challenge.
Interestingly, whereas we show that a caspase can be
an upstream activator of SREBPs, caspases were also
found downstream. The gene encoding for caspase-2
was indeed found to be a target of both SREBP-2 (Logette
et al., 2005a) and SREBP-1c (Logette et al., 2005b). These
findings and the present study suggest a complex inter-
play between caspases and SREBPs, as well as between
intracellular ion composition and lipid metabolism. These
mechanisms are likely to be important to regulate lipid ho-
meostasis in mammalian cells, both under physiological
conditions and during disease.
Finally, the present study, combinedwith recent findings
in the literature, illustrates the complexity of the cellular
response to pore formation by bacterial toxins. Major
changes induced by membrane permeabilization include
loss of transmembrane potential (Abrami et al., 1998),
massive entry of calcium (Krause et al., 1998; Ribardo
et al., 2002), osmotic stress (Ratner et al., 2006), and efflux
and influx of small ions along their respective gradients
(Abrami et al., 1998; Walev et al., 1995). Each of these
events appears to trigger signaling pathways, some of
which are aimed at warning the immune system, while
others appear to promote death or survival of the attacked
cell. For example, toxin-induced increases in cytosolic cal-
cium can trigger activation of the NF-kB pathway (Fickl
et al., 2005; Ribardo et al., 2002), whereas toxin-induced
osmotic stress was found to activate p38 MAPK (Ratner
et al., 2006). Interestingly, activation of p38 leads, on one
hand, to the release of chemokines such as IL-8 (RatnerInc.
Figure 7. Toxin-Induced Changes in Cy-
toplasmic Ion Composition Trigger Cas-
pase-1-Dependent SREBP Activation
and Cell Survival
Aerolysin leads to the permeabilization of the
plasma membrane to ions. Decrease in intra-
cellular potassium triggers the assembly of
both IPAF and NALP3 inflammasomes, which
allow the activation of caspase-1. Through
a yet-to-be-determined intermediate, cas-
pase-1 triggers export of SREBPs from the
ER and its subsequent proteolytic processing
in the Golgi by S1P and S2P proteases. The re-
leased transcription factor migrates to the nu-
cleus, where it activates genes harboring an
SRE in their promoter. Lipid metabolic path-
ways are thus activated. This sequence of
events contributes to cell survival.et al., 2006) and, on the other, switches on a survival path-
way, at least in nonimmune cells (Huffman et al., 2004). It
indeed appears that, depending on the cell type, survival
pathways may be preferentially triggered, whereas in
others, in particular cells of the immune system, apoptotic
pathways are rapidly switched on (Bantel et al., 2001; Ga-
lindo et al., 2004b; Nelson et al., 1999). It will be of interest
in the future to identify the full rangeof cellular changes that
are sensed by pore-forming toxin-treated cells, how the
cells respond to them, and how the balance between sur-
vival and death pathways is regulated.
EXPERIMENTAL PROCEDURES
Cells, Reagents, Cholesterol, and Potassium Determinations
CHO and HeLa cells were grown as described (Abrami et al., 2003).
Human fibroblasts were grown in a 15% FCS DMEM medium. SRD-
12B cells (S1P/, [Rawson et al., 1998]) andM19 cells (S2P/, [Raw-
son et al., 1997]) deficient in the site 1 and site 2 proteases, respec-
tively, were obtained from J. Goldstein. WT and mutant aerolysins
and Staphylococcus a-toxin were purified as described respectively
(Buckley, 1990; Vecsey-Semjen et al., 1996). Cerulenin, valinomycin,
and 25OH Chol were purchased from Sigma, 19-hydroxycholesterol
from Steraloids, Ac-YVAD-chloromethylketone from Bachem, anti-
hamster SREBP-2 monoclonal antibodies form ATCC (Clones CRL-
2198, Rockville, MD), anti-human SREBP-1 from Santa Cruz, CA,
HRP secondary antibodies from Pierce.
Cellular [K+] was determined by flame photometry using a Philips
PYE UNICAM SP9 spectrophotometer (Abrami et al., 1998). Cellular
cholesterol was measured using the Ampex Red detection kit (Molec-
ular Probes).
Toxin Treatment, Cell Viability, Subcellular Fractionation,
and Biochemical Analyses
Unless specified otherwise, cells were treated with 0.2 nM proaeroly-
sin in tissue-culture medium in the CO2 incubator. Low-potassiumCell 1medium refers to Hanks buffer (140 mM NaCl, 5 mM KCl, 10 mM
Hepes, 1.3 mM CaCl2, 0.5 mM MgCl2, 0.36 mM K2HPO4, 0.44 mM
KH2PO4, 5.5 mM D-glucose, 4.2 mM NaHCO3), and high-potassium
medium was identical with the exception of the NaCl (5 mM) and
KCl concentrations (140 mM). Membrane and nuclear extracts were
prepared as described (Wang et al., 1994). Eighty micrograms of
each fraction was analyzed by SDS-PAGE, followed by Western blot-
ting using an anti-SREBP-2 monoclonal antibody, unless specified
otherwise.
Cell Viability and FLICA Staining
Propidium iodide staining (2 mg /ml, Molecular Probes) was performed
for 5 min in the CO2 incubator. Cells are then analyzed by fluores-
cence-activated cell sorter (FACS). FLICACasp1 (Immunochemistry
Technologies), which labels active caspase-1, was added to the cul-
ture medium during the last hour of toxin incubation. Cells were then
washed, and the number of FLICACasp1-positive cells determined by
FACS analysis.
RNA Differential Display
CHO cells were treated or not with 0.1 nM proaerolysin for 1 or 3 hr.
RNA differential display was performed according to the described
ADDER method (Kornmann et al., 2001). Upregulated messenger
bands were extracted from the sequencing gels and processed for se-
quencing as described (Kornmann et al., 2001).
Immunofluorescence
CHO cells were fixed 15 min with paraformaldehyde 3%, permeabi-
lized with saponin 0.1% in PBS-BSA 0.5% for 5 min, and labeled
with anti-SREBP-2 monoclonal antibodies followed by FITC-conju-
gated secondary antibodies (Molecular Probes). Images were ac-
quired using a 1003 lens on an Axiophot (Carl Zeiss Microimaging,
Inc.), equipped with a Hamamastu cooled camera using the Openlab
acquisition software.
Plasmids, RNAi Duplexes, Transfections, and Real-Time PCR
The CMV-INSIG-1-Myc plasmid was from ATCC (Clone 88099). Hu-
man ASC was cloned into the PCR3.V66-Met-FLAG mammalian26, 1135–1145, September 22, 2006 ª2006 Elsevier Inc. 1143
expression vector, human IPAF in the pCR3.V62-Met-FLAG vector,
human FLAG-NALP3 in the pCR3 vector, and caspase-1 in the
pCDNA3 vector. HeLa cells were transfected with 1 mg cDNA/9.6
cm2 plate using Fugene (Roche Diagnostics Corporation). For gene si-
lencing, HeLa cells were transfected for 24 hr with 200 pmol/9.2 cm2
dish of siRNA using Oligofectamine (Invitrogen) transfection reagent.
The following RNAi duplexes were purchased from Quiagen: AACTG
GACCTGCAAGGACTTG against ASC (Dowds et al., 2004), AAGCTT
CAGGTGTTGGAATTA and GCATGATCTCTCAGCAAAT against
NALP3 and AACTGGGCTCCTCTGTAAATA, and AAGTGCTCTGGAC
TTCATTAA against IPAF. siRNAs against S1P from Quiagen, against
caspase-1, caspase-3, SCAP, S2P, SREBP-1, and SREBP-2 from
Santa Cruz, CA.
For real-time PCR, RNA was extracted from a confluent 10 cm dish
of HeLa cells treated or not with proaerolysin and transfected or not
with siRNAs using commercial RNA easyminiextraction kits (Quiagen).
RNA was quantified by spectrometry and 1 mg was used for reverse
transcription using hexanucleotides (Roche). A 1/40 dilution of the
cDNA was used to perform the real-time PCR using the Cyber Green
reagent (Roche).
Supplemental Data
Supplemental Data include 11 figures and can be foundwith this article
online at http://www.cell.com/cgi/content/full/126/6/1135/DC1/.
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